Corporate Profile
Prelude is a clinical-stage biopharmaceutical company designing and developing a pipeline of novel, orally bioavailable, small molecule therapies that target key drivers of cancer cell growth, survival and resistance.
Change
Volume
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.